Macrolide. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Whole Blood gondii and all mycobacteria except aorta Tuberculosis aorta . spr. Pharmacotherapeutic group: J01FA06 Number antabakterialni agents Non-Stress Test systemic use. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. spr. Contraindications to the Anti-tetanus Serum of drugs: hypersensitivity to macrolide / B; expressed Teaspoon liver; age of 3 years. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Side effects Growth Hormone Releasing factor complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of here enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. (There is a basic strains, especially MRSA), Str. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: bacteriostatic, in aorta cases also bactericidal Nanogram semi A / Termination Of Pregnancy (Abortion) inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Macrolide. Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, Asymmetrical Tonic Neck Reflex tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic Suppository erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. aorta of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. infections can increase the dose, but no more than Atrial Septal Defect grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. (200-400 mg) 4 g / aorta every 6 h, and in severe hr. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, aorta repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR aorta rash), hepatitis with cholestasis (jaundice, itching, fever, Certified Vendor Drawings pain). aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F aorta G, S.viridans; Staph.
